Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder

1 references·9 citing·41 second hop

FromToDepth

this work references cited by second hop

References

2000Decrease in Caudate Glutamatergic Concentrations in Pediatric Obsessive-Compulsive Disorder Patients Taking Paroxetine377 cited

Cited by

2011Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder116 cited
2022Treatment-resistant OCD: Pharmacotherapies in adults87 cited
2010Review of the Use of the Glutamate Antagonist Riluzole in Psychiatric Disorders and a Description of Recent Use in Childhood Obsessive-Compulsive Disorder84 cited
2017Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder83 cited
2008Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder82 cited
2008Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults80 cited
2008Brain Imaging in Pediatric Obsessive-Compulsive Disorder77 cited
2009Glutamatergic modulatory therapy for Tourette syndrome74 cited
2011Advances in pharmacotherapy for pediatric anxiety disorders44 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work